Performance of NVS Novartis AG ADR | 2.2% in 12m
Compare NVS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Novartis AG ADR with its related Sector/Index XLV
Performance Duell NVS vs XLV
| TimeFrame | NVS | XLV |
|---|---|---|
| 1 Day | -0.07% | 0.25% |
| 1 Week | -0.17% | 0.62% |
| 1 Month | 3.07% | -2.22% |
| 3 Months | -2.64% | -0.46% |
| 6 Months | 8.87% | 11.43% |
| 12 Months | 2.17% | 7.26% |
| YTD | -0.01% | 1.84% |
| Rel. Perf. 1m | 0.34 | |
| Rel. Perf. 3m | -0.22 | |
| Rel. Perf. 6m | -0.56 | |
| Rel. Perf. 12m | -0.46 |
Is Novartis AG ADR a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Novartis AG ADR (NYSE:NVS) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 60.29 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVS as of May 2024 is 92.84. This means that NVS is currently overvalued and has a potential downside of -4.55% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVS as of May 2024 is 92.84. This means that NVS is currently overvalued and has a potential downside of -4.55% (Sold with Premium).
Is NVS a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 7
- Sell: 1
- Strong Sell: 0
Values above 0%: NVS is performing better - Values below 0%: NVS is underperforming
Compare NVS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.77% | 4.63% | -9.60% | -24.95% |
| US NASDAQ 100 | QQQ | -1.21% | 4.57% | -10.02% | -36.00% |
| US Dow Jones Industrial 30 | DIA | -1.34% | 4.17% | -5.75% | -15.83% |
| German DAX 40 | DBXD | 0.72% | 5.14% | -9.40% | -10.98% |
| UK FTSE 100 | ISFU | -1.83% | -0.14% | -5.50% | -7.28% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.68% | -0.56% | 5.66% | 11.95% |
| Hongkong Hang Seng | HSI | -5.93% | -4.99% | 10.07% | 16.04% |
| Japan Nikkei 225 | EXX7 | -2.52% | 7.88% | -4.75% | -18.24% |
| India NIFTY 50 | INDA | -0.95% | 1.04% | -10.56% | -26.94% |
| Brasil Bovespa | EWZ | -2.61% | 2.38% | 3.99% | -22.09% |
NVS Novartis AG ADR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.29% | 6.21% | -10.47% | -36.10% |
| Consumer Discretionary | XLY | -1.31% | 4.21% | -2.61% | -21.15% |
| Consumer Staples | XLP | -0.55% | 1.26% | -3.16% | 0.29% |
| Energy | XLE | 3.14% | 7.74% | 0.18% | -19.08% |
| Financial | XLF | 0.49% | 5.71% | -12.22% | -26.97% |
| Health Care | XLV | -0.79% | 5.29% | -2.56% | -5.09% |
| Industrial | XLI | -0.26% | 4.89% | -13.00% | -23.78% |
| Materials | XLB | -0.18% | 6.68% | -5.97% | -13.71% |
| Real Estate | XLRE | -1.71% | 6.74% | 1.58% | -2.79% |
| Technology | XLK | -1.53% | 5.40% | -9.51% | -35.57% |
| Utilities | XLU | -3.52% | -2.01% | -3.68% | -1.79% |
| Aerospace & Defense | XAR | -2.65% | 1.42% | -6.70% | -21.29% |
| Biotech | XBI | -7.94% | 4.23% | -17.07% | -5.99% |
| Homebuilder | XHB | -1.62% | 6.21% | -27.47% | -47.84% |
| Retail | XRT | -0.44% | 5.79% | -10.18% | -21.29% |
Does Novartis AG ADR outperform its market, is NVS a Sector Leader?
No, over the last 12 months Novartis AG ADR (NVS) made 2.17%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.26%.
Over the last 3 months NVS made -2.64%, while XLV made -0.46%.
No, over the last 12 months Novartis AG ADR (NVS) made 2.17%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.26%.
Over the last 3 months NVS made -2.64%, while XLV made -0.46%.
| Period | NVS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.07% | -2.22% | -1.56% |
| 3 Months | -2.64% | -0.46% | 3.75% |
| 12 Months | 2.17% | 7.26% | 27.12% |